Circulation. 2005;112:1636-1643
Published online before print September 6, 2005,
doi: 10.1161/CIRCULATIONAHA.104.525550
(Circulation. 2005;112:1636-1643.)
© 2005 American Heart Association, Inc.
Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein ENull Mice
Masaru Iwai, MD, PhD;
Rui Chen, MD, PhD;
Zhen Li, MD, PhD;
Tetsuya Shiuchi, PhD;
Jun Suzuki, MD, PhD;
Ayumi Ide, BS;
Masahiro Tsuda, MD, PhD;
Midori Okumura, MD;
Li-Juan Min, MD;
Masaki Mogi, MD, PhD;
Masatsugu Horiuchi, MD, PhD
From the Department of Molecular and Cellular Biology, Division of Medical Biochemistry and Cardiovascular Biology, Ehime University School of Medicine, Shitsukawa, Tohon, Ehime, Japan.
Correspondence to Masatsugu Horiuchi, MD, PhD, Department of Molecular and Cellular Biology, Division of Medical Biochemistry and Cardiovascular Biology, Ehime University School of Medicine, Shitsukawa, Tohon, Ehime 791-0295, Japan. E-mail horiuchi{at}m.ehime-u.ac.jp
Received November 29, 2004; revision received April 21, 2005; accepted June 13, 2005.
Background The role of angiotensin II (Ang II) type 2 (AT2) receptor in atherosclerosis was explored with the use of AT2 receptor/apolipoprotein E (ApoE)double-knockout (AT2/ApoE-DKO) mice, with a focus on oxidative stress.
Methods and Results After treatment with a high-cholesterol diet (1.25% cholesterol) for 10 weeks, ApoE-knockout (KO) mice developed atherosclerotic lesions in the aorta. In AT2/ApoE-DKO mice receiving a high-cholesterol diet, the atherosclerotic changes were further exaggerated, without significant changes in plasma cholesterol level and blood pressure. In the atherosclerotic lesion, an increase in superoxide production, NADPH oxidase activity, and expression of p47phox was observed. These changes were also greater in AT2/ApoE-DKO mice. An Ang II type 1 (AT1) receptor blocker, valsartan, inhibited atherosclerotic lesion formation, superoxide production, NADPH oxidase activity, and p47phox expression; these inhibitory effects were significantly weaker in AT2/ApoE-KO mice. We further examined the signaling mechanism of the AT2 receptormediated antioxidative effect in cultured fetal vascular smooth muscle cells. NADPH oxidase activity and phosphorylation and translocation of p47phox induced by Ang II were inhibited by valsartan but enhanced by an AT2 receptor blocker, PD123319.
Conclusions These results suggest that AT2 receptor stimulation attenuates atherosclerosis through inhibition of oxidative stress and that the antiatherosclerotic effect of valsartan could be at least partly due to AT2 receptor stimulation by unbound Ang II.
CLINICAL PERSPECTIVE
This article has been cited by other articles:

|
 |

|
 |
 
L.-J. Min, M. Mogi, J. Iwanami, J.-M. Li, A. Sakata, T. Fujita, K. Tsukuda, M. Iwai, and M. Horiuchi
Angiotensin II Type 2 Receptor Deletion Enhances Vascular Senescence by Methyl Methanesulfonate Sensitive 2 Inhibition
Hypertension,
May 1, 2008;
51(5):
1339 - 1344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hashimoto, M. Kihara, N. Imai, S.-i. Yoshida, H. Shimoyamada, H. Yasuzaki, J. Ishida, Y. Toya, Y. Kiuchi, N. Hirawa, et al.
Requirement of Apelin-Apelin Receptor System for Oxidative Stress-Linked Atherosclerosis
Am. J. Pathol.,
November 1, 2007;
171(5):
1705 - 1712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yusof, K. Kamada, F. Spencer Gaskin, and R. J. Korthuis
Angiotensin II mediates postischemic leukocyte-endothelial interactions: role of calcitonin gene-related peptide
Am J Physiol Heart Circ Physiol,
June 1, 2007;
292(6):
H3032 - H3037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oelze, A. Warnholtz, J. Faulhaber, P. Wenzel, A. L. Kleschyov, M. Coldewey, U. Hink, O. Pongs, I. Fleming, S. Wassmann, et al.
NADPH Oxidase Accounts for Enhanced Superoxide Production and Impaired Endothelium-Dependent Smooth Muscle Relaxation in BK{beta}1-/- Mice
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2006;
26(8):
1753 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|